Celldex Stock Falls On Unusually High Volume (CLDX)
NEW YORK (
) --
(Nasdaq:
) is trading at unusually high volume Monday with 3.3 million shares changing hands. It is currently at two times its average daily volume and trading down 83 cents (-3.9%) at $20.44 as of 11:45 a.m. ET.
- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
Celldex has a market cap of $1.51 billion and is part of the health care sector and drugs industry. Shares are up 217% year to date as of the close of trading on Friday.
Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of novel therapeutics for human health care primarily in the United States.
TheStreet Ratings rates
Celldex
as a
. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income and weak operating cash flow. You can view the full
.
See all heavy volume stocks in our
stocks moving on unusual volume list
or get investment ideas from our
.
.
null